Dr. Jing Liu joined the HBHL team on August 1st, 2017, as the Project Manager. She brings an extensive experience in project management, business development and operation to the team.
Jing graduated from McGill University in 1995 with a Ph.D. degree in genetics/genomics, followed by a successful post-doc at Harvard University in the lab of Dr. Robert Brown. Liu et al., Nat Genet.
In 1998, Jing became Group Leader and then Director of Functional Genomics and Preclinical at PhageTech Inc. During this time, Jing directed a research group that integrated genomics, functional genomics, proteomics and pre-clinical studies towards the discovery of new antibiotics. Liu et al., Nat Biotechnol.
From 2005 to 2008, Jing was Director of the McGill Life Sciences Complex High throughput Screening facility (HTS) where she established a high content screening (HCS) platform. The facility provided technical support and advised clients on HTS/HCS assay design and implementation, data analysis and mining, and structure-activity relationship (SAR) follow-up.
From McGill University, Jing moved to New World Laboratories, a biotech company that specializes in the R&D of regeneration products for the nervous system. As Director of Preclinical R&D she was responsible for establishing targeted research programs and improved R&D workflows for increased productivity.
From 2010 to 2015, Jing was in charge of operations, business and administration for the Clinical Proteomics Platform and Systems Medicine Program of the Research Institute of McGill University Health Centre (RI-MUHC). She was also responsible for multi-disciplinary large-scale grant applications and funded projects management, including a FRSQ funded large team grant and a NIH funded R24 grant.
From April 2015 to July 2017, Jing was the Manager of the Infectious Diseases and Immunity in Global Health (IDIGH) Program at the RI-MUHC. She managed all aspects of the program’s activities, including financial, scientific, business, administrative processes, outreaching and training. The outstanding management, operation and integration of fundamental, clinical, epidemiological and health outcomes research of the program was well noted by the RI-MUHC’s Scientific Advisory Committee, receiving the highest scores, and was the only one that was ranked “exceptional” by FRQS among 8 programs of the RI-MUHC. Since August, 2017, Jing continues to provide assistance to the IDIGH program by playing a role of Business and Operation Consultant.
Although trained as a scientist, Jing has always been interested in business and innovation. She has theoretical knowledge (Mini MBA from McGill Executive Institute) of business, operation, administration, team building and finance, which she continuously applies to her daily life.
Jing is also a passionate gardener. She has created and maintained the website for the horticultural society of her neighborhood.